Épron Quievy & Associé advised Paltech SAS within it’s second fundraising
After a first fundraising in 2021, Paltech SAS closed in October 2023 a new round of more than one million euros fully subscribed by private investors.
Founded by doctors Réginald Allouche and Charles-Henri Malbert in 2021, Paltech SAS is an innovative company dedicated to the research for a curative treatment for type 2 diabetes.
Type 2 diabetes is a developing disease that affects more than 800 million people worldwide. The complications induced by this disease both in medium and long terms are strongly disabling. Type 2 diabetes is notably the main cause in non-traumatic amputations, blindness, kidney failure and neuropathy. Most treatments currently available are palliative and allow individuals to live with the disease without curing it. Paltech is developing a medical device that under certain conditions might cure people with type 2 diabetes. The first experiments made it possible to validate the proof of concept. Clinical trials with human beings are planned to start in 2025.
Paltech SAS is assisted by Épron Quievy & Associés on a day-to-day basis with Étienne Épron, partner and Cassandra Gimbert, associate.
More info on Paltech http://www.paltech.fr
Latest news
October 4, 2026
Decision of the General court of the EU – Vladimir Avetisyan
Following last week’s victory in the Tkach case (Case T-584/24), the EQA law firm team is proud to announce a new judicial victory, obtained on 30 September 2026 before the General Court of the European Union, on behalf of Vladimir Avetisyan (Case T-323/25). Subject to European restrictive measures since 24 June 2024, Mr. Avetisyan was supported… Continue reading Decision of the General court of the EU – Vladimir Avetisyan
September 23, 2026
Decision of the General court of the EU – Oleg Tkach
The entire EQA team is proud to announce the victory secured on September 23, 2026, before the General Court of the European Union on behalf of Oleg Polikarpovich Tkach | Case T-584/24. Oleg Tkach had been subject to European restrictive measures since 2022. Etienne Epron, Cassandra Gimbert, Alexandre Genko, and Maximilien Dechamps have assisted him since… Continue reading Decision of the General court of the EU – Oleg Tkach
April 21, 2026
EQA Avocats Recognised Once Again in the Le Monde du Droit 2026 Rankings
Last year, we made a strong appearance in the Le Monde du Droit law firm rankings, earning a gold medal in Private Equity and a bronze medal in Mergers & Acquisitions (under €50 million). Two distinctions, a wonderful surprise, and a great source of pride. This year, thanks to your support, we are pleased to… Continue reading EQA Avocats Recognised Once Again in the Le Monde du Droit 2026 Rankings
March 2, 2026
Restrictive Measures of the EU: Insights from Étienne Épron on OMERTA Media
Étienne Épron was invited by Régis Le Sommier to speak as part of the Grands Entretiens series hosted by OMERTA Media. This discussion provided an opportunity to shed light on the European Union’s restrictive measures and how they operate. 🎥 Watch the interview: https://www.youtube.com/watch?v=KddA206fOWw